Steg Ph Gabriel, Bhatt Deepak L, Wilson Peter W F, D'Agostino Ralph, Ohman E Magnus, Röther Joachim, Liau Chiau-Suong, Hirsch Alan T, Mas Jean-Louis, Ikeda Yasuo, Pencina Michael J, Goto Shinya
Département de Cardiologie, Hôpital Bichat-Claude Bernard, Paris, France.
JAMA. 2007 Mar 21;297(11):1197-206. doi: 10.1001/jama.297.11.1197.
Few data document current cardiovascular (CV) event rates in stable patients with atherothrombosis in a community setting. Differential event rates for patients with documented coronary artery disease (CAD), cerebrovascular disease (CVD), or peripheral arterial disease (PAD) or those at risk of these diseases have not been previously evaluated in a single international cohort.
To establish contemporary, international, 1-year CV event rates in outpatients with established arterial disease or with multiple risk factors for atherothrombosis.
DESIGN, SETTING, AND PARTICIPANTS: The Reduction of Atherothrombosis for Continued Health (REACH) Registry is an international, prospective cohort of 68 236 patients with either established atherosclerotic arterial disease (CAD, PAD, CVD; n = 55 814) or at least 3 risk factors for atherothrombosis (n = 12 422), who were enrolled from 5587 physician practices in 44 countries in 2003-2004.
Rates of CV death, myocardial infarction (MI), and stroke.
As of July 2006, 1-year outcomes were available for 95.22% (n = 64 977) of participants. Cardiovascular death, MI, or stroke rates were 4.24% overall: 4.69% for those with established atherosclerotic arterial disease vs 2.15% for patients with multiple risk factors only. Among patients with established disease, CV death, MI, or stroke rates were 4.52% for patients with CAD, 6.47% for patients with CVD, and 5.35% for patients with PAD. The incidences of the end point of CV death, MI, or stroke or of hospitalization for atherothrombotic event(s) were 15.20% for CAD, 14.53% for CVD, and 21.14% for PAD patients with established disease. These event rates increased with the number of symptomatic arterial disease locations, ranging from 5.31% for patients with risk factors only to 12.58% for patients with 1, 21.14% for patients with 2, and 26.27% for patients with 3 symptomatic arterial disease locations (P<.001 for trend).
In this large, contemporary, international study, outpatients with established atherosclerotic arterial disease, or at risk of atherothrombosis, experienced relatively high annual CV event rates. Multiple disease locations increased the 1-year risk of CV events.
在社区环境中,鲜有数据记录稳定型动脉粥样硬化血栓形成患者当前的心血管(CV)事件发生率。既往尚未在单一国际队列中评估有记录的冠状动脉疾病(CAD)、脑血管疾病(CVD)或外周动脉疾病(PAD)患者或有这些疾病风险的患者的差异事件发生率。
确定患有已确诊动脉疾病或有动脉粥样硬化血栓形成多种危险因素的门诊患者的当代国际1年CV事件发生率。
设计、地点和参与者:持续健康动脉粥样硬化血栓形成减少(REACH)注册研究是一项国际前瞻性队列研究,纳入了68236例患者,这些患者要么患有已确诊的动脉粥样硬化性动脉疾病(CAD、PAD、CVD;n = 55814),要么有至少3种动脉粥样硬化血栓形成危险因素(n = 12422),于2003年至2004年从44个国家的5587个医生诊所招募。
CV死亡、心肌梗死(MI)和卒中发生率。
截至2006年7月,95.22%(n = 64977)的参与者有1年结局数据。总体CV死亡、MI或卒中发生率为4.24%:已确诊动脉粥样硬化性动脉疾病的患者为4.69%,仅具有多种危险因素的患者为2.15%。在已确诊疾病的患者中,CAD患者的CV死亡、MI或卒中发生率为4.52%,CVD患者为6.47%,PAD患者为5.35%。已确诊疾病的CAD、CVD和PAD患者发生CV死亡、MI或卒中终点事件或因动脉粥样硬化血栓形成事件住院的发生率分别为15.20%、14.53%和21.14%。这些事件发生率随有症状动脉疾病部位数量的增加而升高,仅具有危险因素的患者为5.31%,有1个部位的患者为12.58%,有2个部位的患者为21.14%,有3个有症状动脉疾病部位的患者为26.27%(趋势P<0.001)。
在这项大型当代国际研究中,患有已确诊动脉粥样硬化性动脉疾病或有动脉粥样硬化血栓形成风险的门诊患者每年发生CV事件的风险相对较高。多个疾病部位增加了1年CV事件风险。